Literature DB >> 22157876

Beyond antipsychotics: pharmacologically-augmented cognitive therapies (PACTs) for schizophrenia.

Neal R Swerdlow1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22157876      PMCID： PMC3238077          DOI： 10.1038/npp.2011.195

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

1.  A meta-analysis of cognitive remediation in schizophrenia.

Authors:  Susan R McGurk; Elizabeth W Twamley; David I Sitzer; Gregory J McHugo; Kim T Mueser
Journal:  Am J Psychiatry       Date:  2007-12       Impact factor: 18.112

2.  D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.

Authors:  Jennifer D Gottlieb; Corinne Cather; Meghan Shanahan; Timothy Creedon; Eric A Macklin; Donald C Goff
Journal:  Schizophr Res       Date:  2011-06-30       Impact factor: 4.939

3.  Are we studying and treating schizophrenia correctly?

Authors:  Neal R Swerdlow
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

4.  Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Authors:  Kerry J Ressler; Barbara O Rothbaum; Libby Tannenbaum; Page Anderson; Ken Graap; Elana Zimand; Larry Hodges; Michael Davis
Journal:  Arch Gen Psychiatry       Date:  2004-11

Review 5.  Neurophysiological biomarkers for drug development in schizophrenia.

Authors:  Daniel C Javitt; Kevin M Spencer; Gunvant K Thaker; Georg Winterer; Mihály Hajós
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

6.  Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor.

Authors:  Til Wykes; Craig Steel; Brian Everitt; Nicholas Tarrier
Journal:  Schizophr Bull       Date:  2007-10-25       Impact factor: 9.306
  6 in total
  15 in total

1.  Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge.

Authors:  Neal R Swerdlow; Savita G Bhakta; Gregory A Light
Journal:  Schizophr Res       Date:  2018-04-05       Impact factor: 4.939

2.  Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.

Authors:  Neal R Swerdlow; Savita Bhakta; Hsun-Hua Chou; Jo A Talledo; Bryan Balvaneda; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2015-06-11       Impact factor: 7.853

3.  Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 4.  Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Ann N Y Acad Sci       Date:  2015-03-09       Impact factor: 5.691

5.  Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients.

Authors:  Neal R Swerdlow; Melissa Tarasenko; Savita G Bhakta; Jo Talledo; Alexis I Alvarez; Erica L Hughes; Brinda Rana; Sophia Vinogradov; Gregory A Light
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 6.  Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.

Authors:  J W Young; M A Geyer
Journal:  J Psychopharmacol       Date:  2014-12-16       Impact factor: 4.153

7.  Memantine effects on auditory discrimination and training in schizophrenia patients.

Authors:  Neal R Swerdlow; Savita G Bhakta; Jo Talledo; Juliana Kotz; Benjamin Z Roberts; Royce Ellen Clifford; Michael L Thomas; Yash B Joshi; Juan L Molina; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2020-09-22       Impact factor: 7.853

8.  Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients.

Authors:  Neal R Swerdlow; Savita G Bhakta; Jo A Talledo; Daniel M Franz; Erica L Hughes; Brinda K Rana; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2017-11-20       Impact factor: 7.853

9.  Relationship between effortful motivation and neurocognition in schizophrenia.

Authors:  Andrew W Bismark; Michael L Thomas; Melissa Tarasenko; Alexandra L Shiluk; Sonia Y Rackelmann; Jared W Young; Gregory A Light
Journal:  Schizophr Res       Date:  2017-06-30       Impact factor: 4.939

10.  Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia.

Authors:  Michael L Thomas; Michael F Green; Gerhard Hellemann; Catherine A Sugar; Melissa Tarasenko; Monica E Calkins; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Allen D Radant; Larry J Seidman; Alexandra L Shiluk; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff; Gregory A Light
Journal:  JAMA Psychiatry       Date:  2017-01-01       Impact factor: 21.596
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.